7 Apr 2025
📦New Duties on Low-Value Imports from China to Combat Opioid Crisis
Further Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China as Applied to Low-Value Imports
Summary
Executive Order 14256 addresses the illicit shipment of synthetic opioids from the People’s Republic of China and Hong Kong. The order revokes duty-free treatment for low-value imports, mandating new duty payments on eligible products entered for consumption after May 2, 2025. It aims to enhance U.S. trade compliance and revenue collection while monitoring the opioid crisis' impact.
Agencies
- Executive Office of the President
Business Impact
$$$ - High
The Executive Order imposes additional duties on low-value imports from the PRC and Hong Kong, particularly those related to synthetic opioids. Businesses involved in importing these items must comply with new duty regulations starting May 2, 2025, which increases costs and affects supply chain dynamics.